ADAMTS9 and cancer: ADAMTS9-AS2 upregulation enhanced cell differentiation and decreased cell proliferation, metastasis, and cancer stem-like properties, and ADAMTS9-AS2 downregulation promoted malignant potential in neuroblastoma cells.